The fund typically commits a minimum of 80% of its total assets, including any capital acquired through borrowing for investment, to the common stocks of enterprises positioned to gain from the progress and utilization of science and technology. Although its portfolio predominantly consists of U.S. common stocks, it retains the flexibility to invest in foreign equities, such as those from emerging markets, aligning with its overall investment mandate. This fund maintains a non-diversified investment approach.
